GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Resonance Health RHT.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.08

-1.30%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$15.8m

FY2017FY2026

Net income

A$1.5m

FY2017FY2026

Free cash flow

A$2.8m

FY2017FY2026

Shareholders' equity

A$11.1m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$15.8mA$11.1mA$8.6mA$4.4mA$3.8mA$3.8mA$3.7mA$3.6mA$2.9mA$2.5m
Gross profitA$14.8mA$11.1mA$8.6mA$4.4mA$3.8mA$3.8mA$3.7mA$3.6mA$2.9mA$2.5m
Research and developmentA$433,866A$961,028A$835,817A$708,251A$716,231A$393,925A$152,280A$63,177A$123,016A$164,471
Operating incomeA$1.5m−A$1.9m−A$879,000−A$1.6m−A$1.8mA$188,190−A$1.2mA$867,089−A$261,000−A$622,000
Net incomeA$1.5m−A$1.7mA$169,303−A$780,000−A$1.1mA$585,858−A$715,000A$1.3mA$224,619−A$304,000
Diluted earnings per share0.00-0.000.00-0.00-0.000.00-0.000.000.00-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$18.7mA$17.9mA$20.3mA$11.0mA$11.7mA$12.4mA$10.5mA$6.4mA$4.7mA$4.6m
Cash and short-term investmentsA$4.8mA$3.0mA$6.9mA$6.4mA$6.8mA$8.9mA$7.0mA$3.1mA$1.5mA$1.7m
Total liabilitiesA$7.6mA$8.5mA$9.4mA$1.0mA$995,576A$611,738A$591,039A$523,063A$551,671A$884,210
DebtA$3.8mA$3.8mA$3.7mA$272,945A$268,224A$60,105A$116,108———
Shareholders' equityA$11.1mA$9.4mA$10.9mA$9.9mA$10.7mA$11.8mA$9.9mA$5.9mA$4.1mA$3.7m
Shares outstanding476m489m451m465m461m461m455m427m403m393m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsA$2.9mA$1.2mA$1.4m−A$157,028−A$1.5mA$1.2mA$1.3mA$1.6mA$377,973−A$282,321
Capital spending−A$94,768−A$443,124−A$377,315−A$467,903−A$703,997−A$395,793−A$250,632−A$347,993−A$546,641−A$477,921
Free cash flowA$2.8mA$805,391A$1.0m−A$624,931−A$2.2mA$772,721A$1.1mA$1.3m−A$168,668−A$760,242

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueA$7.8mA$8.0mA$5.9mA$5.2mA$5.3mA$3.3mA$2.3mA$2.1m
Gross profitA$7.3mA$7.5mA$5.9mA$5.2mA$5.3mA$3.3mA$2.4mA$2.1m
Operating incomeA$424,508A$1.1mA$834,404−A$599,000A$774,847−A$712,000−A$331,000−A$494,000
Net incomeA$47,060A$1.5m−A$696,747−A$1.0mA$726,855−A$558,000−A$529,000−A$252,000
Diluted earnings per share0.000.00-0.00-0.000.00-0.00-0.00-0.00
Cash from operationsA$2.0m——A$1.0mA$1.0m———
Total assetsA$18.7mA$18.0mA$17.9mA$17.9mA$20.3mA$10.9mA$11.0mA$11.7m
Cash and short-term investmentsA$4.8mA$2.7mA$3.0mA$3.5mA$6.9mA$5.9mA$6.4mA$6.5m
DebtA$2.8mA$4.0mA$3.8mA$3.6mA$3.7mA$320,895A$272,944A$318,570
Shareholders' equityA$11.1mA$10.9mA$9.4mA$10.0mA$10.9mA$9.8mA$9.9mA$10.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue52.9%33.0%20.0%
Operating income—52.1%—
Net income—20.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin96.4%97.6%98.0%98.5%
Operating margin-1.5%-7.3%-9.5%-9.5%
Net margin-0.8%-2.1%-2.9%-2.1%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings23.9-13.8149.0-35.7-24.2110.2-152.775.6107.6-28.4
Price to sales2.32.22.96.37.217.129.826.58.33.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 15 Oct 2003

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.